New insights into the pharmacokinetics of remdesivir in treating SARS-CoV-2 in pregnant women

"Pregnant people are often left behind in clinical research, and because of this, there's usually not much supporting data available for health care providers about the appropriate dosage, safety and effectiveness of medications in this population," said Kristina Brooks, PharmD.